HYPERION THERAPEUTICS INC
DelistedCIK 1386858fmd_082ZDF67THWB5HCECM2VXKZQTMManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2007 to Mar 31, 2015, 21 periods
| Line item | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | 42 | 114 |
| Cost of revenue | – | – | – | – | – | – | 7 | 14 |
| Gross profit | – | – | – | – | – | – | 35 | 100 |
| Research and development | – | – | – | 23 | 17 | 17 | 10 | 21 |
| Selling, general and administrative | – | – | – | 3 | 9 | 11 | 36 | 49 |
| Total operating expenses | – | – | – | 27 | 26 | 29 | 56 | 118 |
| Operating income | – | – | – | (27) | (26) | (29) | (13) | (4) |
| Interest expense | – | – | – | 0 | 3 | 4 | 2 | 2 |
| Interest and investment income | – | – | – | 0 | 0 | 0 | 0 | 1 |
| Other non-operating income (expense) | – | – | – | 1 | (1) | (0) | 1 | (1) |
| Income before taxes | – | – | – | – | (29) | (32) | 17 | (6) |
| Income tax expense | – | – | – | – | – | – | 0 | 0 |
| Net income from continuing operations | – | – | – | – | – | – | 17 | (6) |
| Net income | (9) | (29) | (14) | (25) | (29) | (32) | 17 | (6) |
| Net income to common shareholders | – | – | – | (25) | (29) | (32) | 17 | (6) |